000
| 02474cam 2200361zi 4500 |
---|
001 | 9.868074 |
---|
003 | CaOODSP |
---|
005 | 20230906144026 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 190207s2019 onc o f000 0 eng d |
---|
020 | |a9780660295244 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-249/2019E-PDF |
---|
245 | 00|aReporting adverse events following immunization (AEFI) in Canada : |buser guide to completion and submission of the AEFI reports. |
---|
246 | 30|aUser guide to completion and submission of the AEFI reports |
---|
246 | 17|aUser guide : |bAEFI report form |
---|
264 | 1|aOttawa, Ontario : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c[2019] |
---|
300 | |a1 online resource (29 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Déclaration de manifestations cliniques inhabituelles (MCI) à la suite d'une immunisation au Canada : guide de l'utilisateur pour remplir et soumettre les rapports de déclaration de MCI. |
---|
500 | |aCover title. |
---|
500 | |a"This guide was developed by the Vaccine Vigilance Working Group and the Public Health Agency of Canada." |
---|
520 | |a"This guide is intended to be used when completing the Report of AEFI for submission to provincial and territorial authorities as well as to PHAC. Its purpose is to provide assistance on how to accurately complete the form. It is not intended to guide treatment. Treatment of all AEFIs should proceed, as appropriate, prior to completing the AEFI form. Following the immediate care of the vaccine recipient, the AEFI form can be completed with all available information. Given the variation in practice between each of the provinces and territories, sections of the form may not be applicable to all settings. If in doubt, please contact your local public health unit"--Guidelines, page 7. |
---|
692 | 07|2gccst|aImmunization |
---|
692 | 07|2gccst|aHandbooks |
---|
710 | 2 |aPublic Health Agency of Canada. |
---|
775 | 08|tDéclaration de manifestations cliniques inhabituelles (MCI) à la suite d'une immunisation au Canada : |w(CaOODSP)9.868076 |
---|
794 | |tReporting adverse events following immunization (AEFI) in Canada : |b2022|w(CaOODSP)9.911403 |
---|
856 | 40|qPDF|s432 KB|uhttps://publications.gc.ca/collections/collection_2019/aspc-phac/HP40-249-2019-eng.pdf |
---|